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Characterization of protein-ligand complexes by nondenaturing mass spectrometry provides
direct evidence of drug-like molecules binding with potential therapeutic targets. Typically,
protein-ligand complexes to be analyzed contain buffer salts, detergents, and other additives
to enhance protein solubility, all of which make the sample unable to be analyzed directly by
electrospray ionization mass spectrometry. This work describes an in-line gel-filtration method
that has been automated and optimized. Automation was achieved using commercial HPLC
equipment. Gel column parameters that were optimized include: column dimensions, flow
rate, packing material type, particle size, and molecular weight cut-off. Under optimal
conditions, desalted protein ions are detected 4 min after injection and the analysis is
completed in 20 min. The gel column retains good performance even after 200 injections. A
demonstration for using the in-line gel-filtration system is shown for monitoring the exchange
of fatty acids from the pocket of a nuclear hormone receptor, peroxisome proliferator
activator- (PPAR) with a tool compound. Additional utilities of in-line gel-filtration mass
spectrometry system will also be discussed. (J Am Soc Mass Spectrom 2008, 19, 239–245)
© 2008 American Society for Mass SpectrometryMass spectrometry (MS) is a powerful techniquefor the study of biomolecular complexes[1– 4]. With the use of spray ionization tech-
niques, volatile buffers at or near physiological pH, and
modified time-of-flight (TOF) mass analyzers [5–7],
many noncovalently bound complexes with molecular
weights 0.5 MDa have been analyzed [8, 9]. A wide
variety of biological interactions have been interrogated
using native state mass spectrometry. For example,
homo- and hetero-protein multimers, proteins associ-
ated with DNA or RNA, and proteins with peptide
cofactors and small molecule ligands have all been
successfully analyzed [1].
In small molecule drug discovery, an important
interaction to be probed is binding of a target protein
with a small molecule ligand. Native state (nondenatur-
ing) mass spectrometry can be used to determine the
presence or absence of drug ligands and in some
instances, used for affinity screening [10, 11]. In the
post-genomic era, nondenaturing mass spectrometry
has been utilized to identify native ligands, endogenous
ligands that activate or deactivate novel drug targets,
for example orphan nuclear hormone receptors [12–18].
Typically, native state MS is used to detect the presence
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doi:10.1016/j.jasms.2007.05.008of the native ligand while additional MS experiments
(GC/MS, exact mass LC/MS, etc.) provide structural
elucidation of the ligand. Native ligand identification
provides insight into the possible biological function of
the protein and further impetus towards designing
highly selective and potent drug molecules using a
structure-based approach.
An additional question posed after native ligand
identification is whether or not the activity of the
receptor is mediated through ligand binding. If the
ligand can be displaced and exchanged with a different
compound, then the protein may be a bona fide drug
target. However, finding the appropriate ligand ex-
change conditions can require screening many different
ligands and solvent conditions. Native state mass spec-
trometry is an ideal method for ligand exchange mon-
itoring, especially when sample preparation time is
minimized.
Direct analysis of protein-ligand complexes is possi-
ble using electrosonic spray ionization [19] and nanos-
pray [20], which are somewhat more tolerant to higher
buffer salt concentrations. Usually the protein-ligand
exchange mixtures contain a wide variety of other
“contaminants” such as non-alkali buffer salts (HEPES
and Tris), detergents (Triton, CHAPS, Brij), reducing
agents (DTT), other solubilizing reagents (glycerol), and
excess exchange ligand. All of these buffer components
make direct detection of the protein-ligand complexes
challenging.
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off-line techniques. Some examples include molecular
weight cut-off membranes or gel-filtration “spin col-
umns.” Molecular weight cut-off membranes typically
require many passes to remove buffer materials and can
take hours before samples are prepared. “Spin col-
umns” are a reasonably fast and efficient way to per-
form buffer exchange (20 min per sample). Both of
these techniques can be multiplexed to improve
throughput, but the complex must remain stable in the
volatile buffers for extended periods of time before MS
analysis. This is particularly important if large sample
batches are to be analyzed.
A more desirable approach for improved throughput
is in-line buffer exchange. Some viable approaches have
been demonstrated recently, including two different
on-line microdialysis devices using a fiber [21] and a
microchip with laminar flow [22]. Both methods have
been utilized to reduce the concentration of nonvolatile
salts with a concomitant improvement in sensitivity.
However, these devices were investigated with simple
salt buffers and not the more complex buffer systems
commonly used for solubilizing recombinant proteins.
A second approach was demonstrated by Cavanagh
et al. in which they used an in-line gel-filtration column
directly coupled to a mass spectrometer [23]. This paper
clearly demonstrated that the technique worked for
protein-protein complexes and DNA-protein complexes
that were stored in complex buffer solutions and
showed an attractive solution to our problems for
monitoring ligand exchanges.
This work describes further advances in the use and
utility of the in-line gel-filtration methodology. To im-
prove ease of use, throughput, and robustness, the
method has been fully automated using standard HPLC
equipment. Also, a careful evaluation of gel packing
material and the column dimensions has been con-
ducted. Using the in-line gel column coupled to a
quadrupole time-of-flight mass spectrometer, results
for an unattended assay (190 injections, 2.6 days of
analysis time) are shown. An example of monitoring a
ligand exchange will be shown using peroxisome pro-
liferator activated receptor delta, PPAR, and a tool
compound, a molecule which has demonstrated bind-
ing in in vitro assays and is suitable for initial in vivo
studies. Additional operating modes with the in-line
gel-filtration column will also be discussed.
Experimental
Materials
The in-line gel column consists of Sephadex G-25 Su-
perfine (GE Healthcare) or Bio-Gel P6-DG fine particle
polyacrylamide gel (BioRad, Hercules, CA) slurry
packed, using a syringe, into a 50 mm by 1.6 mm i.d.
PEEK tube (Upchurch, Oak Harbor, WA). Adapter
fittings (10-32 to 1/4-28 in.) with 1/8 in. flangeless nuts
and ferrule are used to connect the column to standard1/16 in. HPLC fittings (Upchurch, Oak Harbor, WA). A 2
m stainless steel frit is used on the 10-32 side of the
adapter fitting to hold the packing material in place.
Ammonium acetate (99.999%), myoglobin, ammonium
hydroxide (PPB/PTFE grade), and Tris(hydroxymethyl)
aminomethane hydrochloride (Tris HCl) were purchased
from Sigma-Aldrich (St. Louis, MO), while glacial acetic
acid was purchased from EM Science (Gibbstown, NJ).
Additional recombinant proteins were obtained from col-
laborators at GlaxoSmithKline or University of California
at San Francisco and injected as delivered.
Apparatus and Procedures
An Agilent (Santa Clara, CA) 1100 Capillary HPLC
stack (thermostatted autosampler, column compart-
ment, degasser, capillary binary pump, and an isocratic
pump) was used to automate sample introduction. The
binary capillary pump flowed 20 mM ammonium ace-
tate buffer at a rate of 10 L/min through the autosam-
pler and into the gel column. The buffer pH was
adjusted by changing the proportion of mobile phase
delivered from Solvent A: pH 6 buffer or Solvent B: pH
8 buffer. The outlet of the gel columnwas connected to the
column switching valve of the LC stack to divert lower
molecular weight materials away from the ionization
source. When the valve was switched, the flow rate was
increased to 20 L/min to increase the efficiency of
removal of the low molecular weight substances from the
column and reduce column re-equilibration time. For
some experiments, the valve was not switched to monitor
the elution of the salt peak. An auxiliary single channel LC
pump was connected to the switching valve to maintain
buffer flow through the ionization source. A typical run
was completed in 20 min.
All mass spectra were collected using a modified
QSTAR-XL (Applied Biosystems/MDS SCIEX, Con-
cord, ON, Canada) quadruple time-of-flight mass spec-
trometer. A cylindrical sleeve was installed around the
Q0 focusing quadrupole to locally increase pressure to
enhance detection of intact protein-ligand complexes
[6]. The instrument was set to acquire data from m/z
1500 to 5000 in 3s. Ions were introduced using
positive ion electrospray with the orifice (DP), ring
(FP), QO, and Q2 potentials optimized for each
protein. The instrument was equipped with a Turbo-
IonSpray source, which was held at a potential of
4.2 kV with the curtain gas at 20 (arbitrary units)
and nebulizer at 50 (arbitrary units). No heat was
applied to the nebulizer.
Results and Discussion
Characterization of the In-Line Gel Column
Recombinant protein solutions that are used to generate
crystals for X-ray crystallographic studies typically are
at high concentrations (1 mg/mL) and are at or near
physiological pH. To maintain solubility, many differ-
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glycerol and DTT are used to maintain solubility and to
prevent protein aggregation. Figure 1a demonstrates
what occurs when myoglobin (0.1 mg/mL) is analyzed
by loop injection from a relatively simple buffer, 10 mM
Tris into the electrospray ionization source. Cluster
ions, comprised of the buffer components, are detected
while protein ions are absent, even though 500 ng of
protein was loaded. Even from this low concentration
buffer, clearly buffer salts and other additives adversely
affect protein detection by ESI-MS.
While off-line exchange techniques such as spin-col-
umns or molecular weight cut-off filters could be used to
exchange the Tris buffer with a volatile buffer before
analysis, we have observed poor recoveries (10%) with
proteins we are interested in analyzing. This is likely to be
Figure 1. Mass spectra obtained for 0.5 ng m
analyzed under nondenaturing conditions and (a
0.75 mm i.d. gel-filtration column packed with
column packed with P6 gel, and (d) with a 1.6
G25. The panels on the left-hand side of (b)–(d)
these experiments, while those on the right-han
ion for myoglobin.attributed to either protein binding to the membrane orreduced solubility after exchange into the assay buffer 20
mM NH4OAc. To reach our goals of reducing the time
that protein samples spend in this weak buffer system and
minimizing sample preparation, we decided to explore
the in-line gel-filtration method.
In in-line gel-filtration experiments, protein mole-
cules and complexes elute before buffer salts, additives,
and unbound ligands. Figure 1b shows an example
when analyzing the myoglobin sample with a 0.75 mm
i.d. PEEK column packed with BioRad P6 gel and using
20 mM ammonium acetate as the elution buffer via the
automated system. This experimental set-up closely
mimics the elution conditions described in the manual
procedure described by Cavanagh et al. [23]. The mass
spectrum consists of three multiply protonated ions at
m/z 1952, 2196, and 2510, which are consistent for
bin solvated in 10 mM Tris HCl buffer when
hout the in-line gel-filtration column, (b) with a
el, (c) with a 1.6 mm i.d. in-line gel-filtration
.d. gel-filtration column packed with Sephedex
sent the base peak chromatograms obtained in
e display an expanded view of the [M  8H]8yoglo
) wit
P6 g
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d sidheme-bound myoglobin.
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failed to detect many proteins, including peroxisome
proliferator activated receptor delta (PPAR) and its
native ligand, (data not shown), using the 0.75 mm i.d.
in-line gel column. One possible reason was a lack of
resolution between the protein and salt peak. As seen in
the left-hand panel of Figure 1b, the myoglobin peak is
not fully resolved from the “salt” peak. At higher buffer
concentration, the resolution becomes worse and a
result similar to that shown in Figure 1a occurs. Other
potential reasons for failing to detect proteins include
providing insufficient column re-equilibration time, ir-
reversible protein binding to the column, or protein
aggregation upon buffer exchange. Additional experi-
ments were conducted to understand these effects and
to improve the performance of the column.
Among the most important parameters for increas-
ing resolution between protein and buffer salts is
matching the flow rate to the i.d. of the column. As
recommended by the gel material manufacturer, the
linear flow rate should range between 2 and 10 cm/h
[24]. Using 0.75 mm i.d. tubing, the linear flow velocity
is 136 cm/h when the flow rate is set at 10 L/min, an
ideal low flow rate for the TurboIonSpray source. By
increasing the tubing size to an i.d. of 1.6 mm and using
a 10 L flow rate, the linear flow rate is reduced to 29.8
cm/h. The data shown in Figure 1c were obtained using
these conditions. The protein peak is fully resolved
from the buffer peak and, clearly, ion suppression
effects due to Tris were minimized. Although these
conditions are not within the optimal conditions for the
gel-filtration media, it is impractical to increase the i.d.
further since increased band-spreading and analysis
time result without any further signal enhancement.
The performance of the gel-column is still sub-
optimal when using 20 mM buffer since the gel media
should be operated with buffers at concentrations 50
mM. We have observed instances when protein recov-
ery was greatly enhanced by increasing the buffer
concentration to 200 mM. In such studies, the protein
was collected off-line and analyzed using nanospray,
since the TurboIonSpray source performs poorly at
such high salt concentrations.
Similar gel-filtration media were also tested that had
either (1) different molecular weight cut-offs ranges, for
example Bio-Gel P-10, or P6 gel, or (2) different pore sizes-
medium and extra fine. No significant enhancements in
performance were found from these investigations.
Slightly worse performance was obtained using a differ-
ent type of desalting gel media, Sephadex G-25, which is
composed of dextran cross-linked with epichlorohydrin
gel beads, (Figure 1d). The ability to change materials by
simply unpacking and repacking the PEEK columns pro-
vides an additional way to optimize analysis.
Finally, we found that the column requires a sufficient
amount of re-equilibration time, e.g., time to remove low
molecular weight materials from the column. We experi-
mentally determined the re-equilibration time, by moni-
toring the TIC produced by background ions beforeinjection and after the buffer peak eluted. In this simple
experiment, it was determined, that the cycle time
should be 20 min since the background returned to its
initial level 10 min after elution of the salt peak (RT
8 min, Figure 1c).
The in-line gel-filtration MS system enables the pos-
sibility to perform multiple analyses in an unattended
fashion since the protein remains in a favorable buffer
system at a controlled temperature, i.e., 4 °C, until it is
analyzed. This operational mode is useful when a given
target protein is dispensed into individual vials or a
96-well plate and is incubated with a series of different
compounds. Since the LC, MS, and switching valve are
controlled by a computer, unattended analysis is feasi-
ble, provided that the in-line gel column is able to
perform well over an extended period of time.
To test stability of the system, 0.1 mg/mL myoglobin
was solubilized in (1) 20 mM Tris, (2) 20 mM NH4OAc,
or (3) 20 mM Tris, 200 mM NaCl at pH 8. In three
separate experiments, each solution was analyzed200
times. Plotted in Figure 2 is the peak area for m/z 2196.9
obtained from these studies. Note that for each injec-
tion, protein was detected and m/z 2196.9 was the base
peak for each mass spectrum (see Figure 1b and c).
Clearly, from these data, the method lacks reproducibil-
ity for quantitative studies, especially when concen-
trated sample buffer [3] was present. However, the
system has sufficient robustness to provide useful qual-
itative data for a large number of samples.
Interestingly, it took about 25 injections for the
system to stabilize when Tris (1) or NH4OAc (2) were
used as the sample buffers. Typically, before using a
freshly prepared column, four or five injections of any
protein, usually 0.1 mg/mL myoglobin, are required
before an appreciable signal is obtained. Perhaps some
protein has to interact with the size exclusion material
or other active sites to maximize the recovery of the
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Figure 2. Integrated peak area for m/z 2196.9 plotted as a
function of the analysis number when analyzed repetitively from
10 mM ammonium acetate (filled square), 10 mM Tris HCl (filled
diamond), and 20 mM Tris, 200 mM NaCl at pH 8 (filled
diamond), respectively.
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during these runs; once the counts exceed 150, the
system is ready for use. For each experimental set, some
extended periods of reproducible results were obtained.
However, after the 150th injection, the signal in both
studies (1) and (2) decreased. Perhaps, the gel material
may have broken down or may have become coated
with excess protein.
With the addition of NaCl to the buffer, sodiated
molecular ions became prominent, which resulted in a
concomitant decrease in the signal at m/z 2196.9. The
baseline observed before the elution of the protein peak
was similar to those observed with the other buffers,
which indicates that there was a sufficient amount of
re-equilibration time. Possibly, a small amount of so-
dium is being trapped by the gel material and it only
elutes when protein is present. We are currently inves-
tigating if the sodium can be exchanged from the gel
material by pulsing in ammonium acetate at a higher
concentration, or by the injection of a second protein to
passivate the column.
At this time, it is still difficult to predict whether a
particular protein will be analyzed successfully by
in-line gel-filtration MS. Potential reasons for failed
analyses include limited solubility of the protein in
ammoniated buffers or protein requiring a particular
buffer component that is removed by the column, or the
buffer system itself could contain a component that
fouls the column. Since the experiments can be con-
ducted quickly, we typically seek to obtain data and
then sort out what factors contribute to the analysis
failing.
Use of In-Line Gel Filtration MS
in Drug Discovery
The in-line gel-filtration MS technique was initially
used to determine the presence of native ligands in the
orphan nuclear hormone receptors: human steroido-
genic factor-1 (SF-1) and liver receptor homolog 1
(LRH-1), which were over-expressed and purified from
bacterial cells [18]. In these studies, it was discovered
that both proteins had the binding pocket occupied
with diacyl phosphatidyl glycerols (PG) and ethano-
lamines (PE), Figure 3a. The in-line gel technique en-
abled us to rapidly examine a series of samples that
clearly demonstrated that both PG and PE ligands
could be exchanged with phosphatidyl inositols (P4,5I
and P3,4,5I). The PI ligands were subsequently pro-
posed to be the native ligands found in eukaryotic
cells. Recently, a sample of hSF-1 recombinantly over-
expressed by baculovirus in Sf9 insect cells, was ana-
lyzed using native state mass spectrometry. Phosphati-
dyl choline (760 Da) and phosphatidyl inositol (834 Da)
were identified as noncovalently bound native ligands,
as is shown in Figure 3b.
The in-line gel MS technique is ideally suited for
monitoring ligand exchange experiments. Figure 4shows an example of displacement of weakly bound
(1 M) fatty acids (m/z 253 and m/z 283), which are
native ligands for PPAR, with a tight binding com-
pound (EC50  1 nM, Structure 1), which has a nominal
MW of 471.5 Da [25]. The extent of ligand exchange is
varied by adjusting the ligand to protein ratio between:
(1) no ligand added, (2) to an excess of protein 1:2, and
(3) to an excess of ligand 5:1. Clearly, the ligand
completely displaces the fatty acids when introduced in
excess.
Displacement of the native ligand becomes more
difficult when it is more tightly bound to the recep-
Figure 3. Deconvoluted native state mass spectra obtained from
the analysis of human steroidogenic factor-1 (hSF-1) for expressed
from (a) E. coli and (b) sf9 cells using baculovirus. In each spectrum
the apo-protein (i.e., mass  30,444 Da in (a) was detected along
with multiple liganded proteins. By changing the expression
system, different native ligands were observed; (a) phosphatidyl
glycerols (mass  720 and 746 Da) and ethanolamines (not
labeled) and (b) phosphatidyl choline (mass  759 Da) and
phosphatidyl inositol (mass  836 Da). Structure elucidation of
the ligands was achieved in separate experiments using accurate
mass and MS/MS experiments (data not shown).tor, the exchange ligand has a weaker binding affin-
ition
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exchange buffer. These are the typical samples pro-
vided for analysis to support early drug discovery
efforts. In such systems, multiple in-line gel-filtration
MS analyses are conducted to determine the extent of
ligand exchange under a variety of different exchange
conditions while using only a small amount of pro-
tein (0.1 mg). The exchange conditions may be
adjusted in one or more of the following ways:
addition of reagents to unfold and then refold the
protein, adjustment of temperature, pH, ligand con-
centration, additives to improve solubility of the
endogenous ligand, and incubation time (3 h to 2 wk).
If the temperature is not a variable for the exchange,
samples can be incubated in vials in the autosampler
and analyzed at times specified by the collaborator.
Once the optimal exchange conditions are estab-
Figure 4. Experiment conducted to mimic the
and 281 Da) with GW610742X (MW 471.5 Da). T
ligand introduced, to (b) 1:2, ligand as the limitin
samples were analyzed within 1 min of the addlished, the remainder of the protein (100 mg or more)is ligand-exchanged, resulting in a solution desig-
nated for crystallization trials. If diffracting crystals
are obtained, these crystals are analyzed by X-ray crystal-
lography to potentially achieve a solved protein-ligand
crystal structure.
itoring of endogenous ligands (fatty acids, 253
gand to protein ratio was varied from (a) 0, no
gent, and (c) 5:1, ligand in excess. Note that the
of the ligand to the protein solution.mon
he li
g reaStructure 1
245J Am Soc Mass Spectrom 2008, 19, 239–245 AUTOMATED IN-LINE GEL FILTRATION FOR NATIVE STATE MSConclusions
In-line gel-filtration provides a convenient means to
introduce samples for native state mass spectrometry.
The use of an the in-line gel column and a modern LC
system enables fully automated sample analysis and
maximizes the time protein complexes are stored in
favorable buffers before analysis. This method has been
successfully used for the analysis of many different
types of protein complexes.
There are, however, instances when the in-line gel-
filtration method fails. Usually this is attributed to the
protein becoming insoluble or aggregating when sam-
ple buffers are exchanged with the 20 mM ammonium
acetate on the column. Typically, the column becomes
plugged and a new one needs to be constructed. Some-
times, increasing the strength of the buffer to 200 mM
and collecting the contents for nanospray or increasing
or decreasing the pH provides an effective alternative
strategy. Perhaps another possible solution to be ex-
plored is to couple the in-line gel-filtration column
operated with higher strength buffers to the microdi-
alysis device. The in-line column could thus be operated
under its optimal conditions and would remove other
small molecules that could foul the microdialysis chip.
With further improvement in robustness, it could be
conceivable to develop a protein-ligand complex
screening open-access [26, 27] work stations based upon
the in-line gel MS technique.
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